Development of advanced three-dimensional tumour models for anti-cancer drug testing
Animal testing is still the common method to test the efficacy of new drugs, but tissue engineered in vitro models are becoming more acceptable for replacing and reducing animal testing in anti-cancer drug screening by developing <em>in vitro</em> three-dimensional (3D) tumour models for...
Autor principal: | Wan, X |
---|---|
Outros Autores: | Cui, Z |
Formato: | Tese |
Idioma: | English |
Publicado em: |
2014
|
Assuntos: |
Registros relacionados
-
Targeting cell adhesion as a method of sensitising metastatic tumour cells to TRAIL-induced apoptosis
por: Phipps, L
Publicado em: (2011) -
Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF
por: Knowles, H, et al.
Publicado em: (2008) -
Heterogeneity of tumour response to hypoxia: carbonic anhydrase IX induction defines a subpopulation of hypoxic cells with stem cell properties and drug resistance
por: Ledaki, I
Publicado em: (2013) -
Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines
por: Mallett, S, et al.
Publicado em: (2010) -
Functional analysis of cancer/testis antigens in human cancer
por: Pagotto, A
Publicado em: (2013)